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EXPRESSION OF ADULT 
T-CELL LEUKEMIA- 
DERIVED FACTOR IN 
BRONCHOALVEOLAR 
LAVAGE CELLS AFTER 
CANINE LUNG 
TRANSPLANTATION 
Lung transplantation is now an accepted therapeutic option for patients with 
end-stage lung disease, and an early diagnosis of rejection is essential in the 
management of these patients. Adult T-cell leukemia-derived factor (ADF), 
known as a human homolog of thioredoxin, has been shown to be induced by 
a variety of stresses. In this study we examined ADF expression i  lung tissues 
and bronchoalveolar l vage cells after canine lung transplantation to deter- 
mine whether it could be induced by allogenic stimulations and could be used 
to diagnose early rejection. Allotransplantations were performed in adult 
mongrel dogs, and immunosuppression was performed from the day of 
operation to the fifth postoperative day. No immunosuppressant was given 
from the sixth to the tenth postoperative days. Animals were put to death on 
the tenth postoperative day. Bronchoalveolar l vage was performed on the fifth 
and tenth postoperative days, and the lavage cells and lung tissues were 
examined immunohistochemically with anti-ADF antibody. The grades of 
rejection were as follows: grade 1 in two animals, grade 2 in three animals, and 
grade 3 in two animals. The percentages of ADF high-producer cells in 
bronchoalveolar lavage cells on the fifth and tenth postoperative days were 
4.29% - 2.65% and 26.6% - 3.99%, respectively (p < 0.01). The percentages of 
ADF high-producer cells in normal healthy dogs and in those with grade 1, 
grade 2, and grade 3 rejection were 3.00% --. 1.64%, 20.5% - 9.00%, 25.5% • 
6.06%, and 34.5% • 6.50%, respectively. The percentage in each rejection 
group was significantly higher than that in normal healthy dogs (p < 0.05). 
These results suggest hat examination of bronchoalveolar lavage cells with 
ADF staining may be useful in the early diagnosis of rejection. (J THORAC 
CARDIOVASC SURG 1995;110:15-21) 
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A dult T-cell leukemia-derived factor (ADF) was first defined as the interleukin-2 receptor (IL- 
2R) oMnducing factor produced by adult T-celt 
leukemia cell linesJ' 2 Complementary deoxyribonu- 
cleic acid cloning of ADF has shown a remarkable 
homology between ADF and Escherichia coli-derived 
thioredoxin, a coenzyme catalyzing the reduction of 
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proteins in prokaryotic systems. 3-5 Thioredoxin con- 
tains a redox active disulfide (-Cys-Gly-Pro-Cys-) and 
has a variety of biologic activities as a hydrogen donor, 
including formation of deoxyribonucleotides from 6- 
bonucleotides catalyzed by ribonucleotide reductase 6 
and degradation of insulin. 4 Furthermore, thioredoxin 
is involved in an electron-transfer system common to a 
variety of organisms and tissues 5 and has radical 
scavenging properties]' 8 ADF expression can also be 
induced by a variety of stresses, including x-rays, 
ultraviolet irradiation, and hydrogen peroxide? On the 
other hand, we have shown in gel retardation assays 
that recombinant ADF markedly enhances the binding 
of NF-KB to the target sequence in IL-2R o~ chain 
promoter. Thus ADF is presumably required in the 
process of activating NF-KB systems. 9 According to 
these findings, it was suggested that ADF expression 
might be induced by allogenic stimulation. In our 
preliminary experiments, we observed no ADF high- 
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producer cells (ADFh cells) in transplanted canine 
lung tissues without rejection, and ADFh ceils in- 
creased as rejection progressedJ ~ We hypothesized 
that ADFh cells in bronchoalveolar l vage (BAL) fluid 
would increase in number as rejection progressed. To 
examine this hypothesis we performed left lung allo- 
transplantation i  adult mongrel dogs and observed 
the expression of ADF in biopsy specimens of the lung 
and in BAL cells. We also tried to determine whether 
analysis of cells from BAL fluid for ADF might be a 
useful tool in the diagnosis and monitoring of early 
rejection. 
Materials and methods 
Animals and anesthesia. Seven adult mongrel dogs 
weighing between 6 and 24 kg were used. General anes- 
thesia was performed by the method described previous- 
ly. 11-~3 All animals received humane care in compliance 
with the "Principles of Laboratory Animal Care" formu- 
lated by the National Society for Medical Research and 
the "Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
publication No 85-23, revised 1985). In addition, we tested 
one animal with pneumonia resistant to therapy and used 
five healthy dogs as negative controis. 
Allotransplantation of the left lung. Allotransplanta- 
tion of the left lung was performed by the method of 
Veith, ~ Yumazaki, la Yokomise, 13 and their coworkers. 
The warm ischemic time for the transplantation was 50 to 
100 minutes. 
Immunosuppression. Optimal doses of FK-506 (sup- 
plied by Fujisawa Pharmaceutical Co., Osaka, Japan) 
were injected intramuscularly (0.1 mg/kg per day) from 
the day of operation to the fifth postoperative dayJ 4 No 
immunosuppressant was administered from the sixth to 
the tenth postoperative days. Penicillin G was given by 
drip infusion on the day of operation and then aminoben- 
zyl penicillin orally for 10 days. 
BAL. A flexible fiberoptic bronchoscope (model P10, 
Olympus Corp., Lake Success, N.Y.) was introduced into 
the transplanted lung up to a subsegmental bronchus. 
Sterile normal saline solution (50 ml) was infused through 
the operating channel, and gentle aspiration was applied. 
This procedure was repeated once. BAL fluid was filtered 
through gauze to remove mucus. BAL cell differential 
counts were performed on Wright-Giemsa-stained 
smears after cytocentrifugation of 2 • 10 4 cells. BAL cell 
counts were performed with a hemocytometer on the fifth 
and tenth postoperative days. 
Antibodies. Rabbit polyclonal antibody against ADF 
was raised by immunization with the ADF C-peptide 
conjugated with bovine serum albumin in the presence of 
complete Freund's adjuvant. The details of the procedure 
of antibody purification have been described previouslyJ 5 
Western blot analysis of recombinant ADF and dog serum 
showed the same 13 kd band (data not shown). 
Immunohistoehemieal analysis of ADF. BAL cell im- 
munohistochemistry was performed on cytocentrifugation 
of 2 • 10 4 cells on glass slides coated with poly-L-lysine. 
The slides were fixed initially with 50% Bouin's solution 
and 50% paraformaldehyde solution and then washed in 
phosphate-buffered saline solution. Lung tissues obtained 
by biopsy on the tenth postoperative day were fixed in 
Bouin's solution for 4 hours, embedded in paraffin, and 
cut into 5 txm thick sections. The slides were dewaxed in 
toluene and dehydrated in graded ethanol solution. Slides 
of cells and tissues were stained as follows:" Endogenous 
peroxidase activity was blocked with hydrogen peroxide 
(0.3% in methanol for 6 minutes). Nonspecific reactions 
were blocked with normal goat serum. The staining pro- 
cedure was performed with a DAKO LSAB Kit (DAKO, 
Carpinteria, Calif.). The slides were incubated with anti- 
ADF antibody 0.4 t~g/ml for 90 minutes at 37 ~ C or normal 
rabbit immunoglobulin as a negative control, then incu- 
bated with a mixture of avidin-biotin horseradish peroxi- 
dase complex, and developed with 3-amino-9-ethylcarba- 
zol. Counterstaining was performed with hematoxylin. 
Histopathology. Serial sections were stained with he- 
matoxylin and eosin. 
Assessment. The degree of rejection was classified ac- 
cording to "The grading of acute rejection by Interna- 
tional Society for Heart Transplantation. '16Two hundred 
BAL cells on a glass slide were counted, and the percent- 
age of ADFh cells was determined. Cell profiles were also 
studied. Each histopathologic assessment was performed 
by two independent pathologists. 
We did not perform biopsies on the fifth postoperative 
day because the procedure might have interfered with the 
experimental results. 
Statistical analysis. All values were expressed as the 
mean _+ standard error. Statistical evaluation of the data 
was performed with Student's t test for either paired or 
unpaired observations. A value of less than 0.05 was 
accepted as significant. 
Results 
Allograft rejection. The grades of rejection were 
as follows: grade 1 in two animals, grade 2 in three 
animals, and grade 3 in two animals. No histologic 
evidence of infection was found in any of the 
specimens. Fig. 1 (grade 2) shows many perivascular 
mononuclear infiltrates surrounding venules and 
arterioles (Fig. 1, A, hematoxylin-eosin stain). Red- 
stained ADFh cells can be seen mainly in the 
perivascular cuffing (Fig. 1, B, ADF stain). 
Analysis of BAL cells. The total cell count in 
BAL fluid obtained from normal healthy dogs was 
4.74 _+ 1.16 • 105/ml. On the fifth and tenth 
postoperative days, it was 5.01 _+ 0.24 • 105/ml and 
4.59 _+ 0.78 x 106/ml, respectively (control versus 
tenth postoperative day and fifth versus tenth post- 
operative day, p < 0.01). As shown in Fig. 2, a few 
ADFh cells were present in the BAL fluid from 
allograft lungs on the fifth postoperative day (Fig. 2, 
A). Significant numbers of ADFh cells were present 
in the BAL fluid from allograft lungs on the tenth 
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Fig. 1. Grade 2 rejection: Many perivascular mononuclear infiItrates urround venules and arterioles (A; 
hematoxylin-eosin stain). Red-stained cells can be seen in the perivascular cuffing (B; ADF stain). 
Fig. 2. A, Allograft BAL cells on postoperative day 5 demonstrating lack of ADFh cells. B, Immunohis- 
tochemical localization of ADF from allograft BAL cells on postoperative day 10. 
18 Ono et aL 









p < 0.01 
I I 
N.S. p < 0.01 
I I I  I 
0 
control Day 5 Day 10 
( normal healthy dogs) 
Fig. 3. Percentages of ADFh cells in BAL cells on the fifth and tenth postoperative days were 4.29% + 
2.65% and 26.6% _+ 3.99%, respectively, and in normal healthy dogs (controls), 3.00% -+ 1.64% (control 
versus tenth postoperative day and fifth versus tenth postoperative day, p < 0.01). The difference between 
the control group and the day 5 group is not significant. 
postoperative day (Fig. 2, B). On the fifth and tenth 
postoperative days the percentages ofADFh cells in 
BAL cells were 4.29% _+ 2.65% and 26.6% _+ 
3.99%, respectively. In the control dogs the percent- 
age was 3.00% -+ 1.64% (control versus tenth post- 
operative day and fifth versus tenth postoperative 
day, p < 0.01, Fig. 3). No significant difference was 
noted between the control group and ~ the groups 
studied on the fifth postoperative day. The percent- 
ages of ADFh cells in lungs with grade 1, grade 2, 
and grade 3 rejection were 20.5% _+ 9.00%, 25.5% 
+_ 6.06%, and 34.5% _+ 6.50%, respectively. The 
percentage of  ADFh cells in each rejection group 
was significantly higher than that in the control dogs 
(p < 0.05, Fig. 4). The percentage of ADFh cells 
increased as rejection progressed, but the differ- 
ences among the rejection groups were not signifi- 
cant. 
Discussion 
An early diagnosis of rejection is essential in the 
management of patients after lung transplantation. 
Open lung biopsy remains the gold standard for the 
diagnosis of rejection. However, the procedure is 
invasive and not always clinically practical. Trans- 
bronchial ung biopsy is less invasive and can be 
performed repeatedly. Unfortunately, inasmuch as  
an accurate diagnosis of rejection requires 12 to 15 
biopsy specimens, a7complications such as bleeding 
and pneumothorax re common. In addition, immu- 
nocompromised hosts with Pneumocystis carinii or 
cytomegalovirus show perivascutar cuffing resem- 
bling that observed in rejected lung allografts, is
Achterrath and coworkers ~9 first advocated the use 
of BAL in transplanted canine lungs in 1975 and 
suggested that BAL might provide early clues to the 
diagnosis of lung allograft rejection. Since then 
several investigations have been reported. 2~ 
In this study we especially investigated ADF 
expression on BAL cells on the fifth and tenth 
postoperative days, using normal healthy dogs as 
controls. Our assumption was that there would be 
no rejection on the fifth postoperative day because 
the animals were receiving immunosuppressant 
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Fig. 4. The percentages ofADFh cells in grade 1, grade 2, and grade 3 rejection were 20.5% _+ 9.00%, 
25.5% _+ 6.06%, and 34.5% _+ 6.50%, respectively. The percentage ofADFh cells in each rejection group 
was significantly higher than that in the controls (p < 0.05). The number of ADFh cells increased as 
rejection progressed, but the differences among the rejection groups were not significant. 
drugs until this time, but that by the tenth postop- 
erative day there would be early rejection. Our 
pathologic data from day 10 animals indicate that 
this approach was valid because these animals 
showed early rejection. We did not perform biopsies 
on day 5 animals because we were concerned that 
this could lead to complications and adversely affect 
our protocol. However, other data indicate that the 
immunosuppression protocol we used is effective. 14 
There were few ADFh cells among the BAL cells 
obtained from the control dogs or from animals on 
the fifth postoperative day when they were well 
immunosuppressed, but on the tenth'postoperative 
day, when we could make a diagnosis of rejection, 
ADFh cells had increased significantly (control ver- 
sus tenth postoperative day and fifth versus tenth 
postoperative day, p < 0.01). The percentage of 
ADFh cells in each rejection group was significantly 
higher than that in the control dogs (p < 0.05). This 
suggests that allogenic stimulation increased the 
number of ADFh cells in BAL fluid. In this model 
we found ADFh cells in the early stage of rejec- 
tion--a critical finding, because to prevent serious 
consequences of rejection, it is necessary to start 
treatment in the early stages of rejection (grade 1 or 
2). It took only 3 hours to perform the immunohis- 
tochemical staining, so that prompt herapy can be 
initiated soon after rejection is suspected. Another 
advantage of this approach is that it is relatively 
simple to apply. 
ADF expression can be induced by a variety of 
stresses. The mechanism by which activated alveolar 
macrophages xpress ADF is not obvious, but there 
is much evidence that dithiol-related reducing con- 
ditions are needed for the in vitro proliferation of 
lymphoid cells. We have shown in gel retardation 
assays that recombinant ADF markedly enhances 
the binding of NF-•B to the target sequence in 
IL-2R o~ chain promoter. Thus ADF may play some 
role in the process of activating NF-KB. 9 We hypoth- 
esize that a similar phenomenon occurs in the 
process of antigen presentation i alveolar macro- 
phages under allogenic stimulation. 
We determined the percentage of ADFh cells in 
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the total BAL cell pool, because it is particularly 
difficult to distinguish small macrophages from me- 
dium-sized or large lymphocytes. Because we 
thought that most cells were macrophages, in an- 
other experiment we tried to show indirectly that 
ADFh cells have phagocytic activity. We incubated 
the BAL cells obtained on the tenth postoperative 
day with Zymosan treated with dog serum. Of the 
cells that morphologically resembled alveolar mac- 
rophages, 95% phagocytized zymosan, and the per- 
centages of ADFh cells before and after incubation 
were 18% and 22%. These data indicate that ADFh 
cells are probably macrophages. Although the clin- 
ical usefulness of this approach appears promissory, 
a number of further studies are clearly required. 
Of particular importance are studies to determine 
whether the measurement of ADFh cells can distin- 
guish between rejection and infection, the usual prob- 
lem facing clinicians. We had a chance to examine 
BAL cells from a dog with pneumonia. The percent- 
age of ADFh cells was 8%. This finding suggests that 
measurement of ADFh cell count can help in distin- 
guishing between rejection and infection. 
In this study we could not determine whether the 
ADFh cells were from the donors or the recipients. 
However, donor lymphocytes and macrophages are 
incompletely replaced by those of the recipient 
during the first 6 weeks after transplantation. 24 
Human leukocyte antigen phenotyping of BAL cells 
or other studies are needed to identify the origin of 
ADFh cells correctly. 
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